Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesco Autore
Observed names:
Autore F,
Autore, Francesco,
F Autore,
F. Autore,
Francecso Autore,
francesco autore
show all 6
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0002-7868-7469
Observed ORCID:
0000-0002-7868-7469
OpenAlex ID:
A5028160176
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
2015
·
F R Mauro
, S Chauvie
, et al.
·
Leukemia
·
79
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review
2018
·
Francesco Autore
, Paolo Strati
, et al.
·
Haematologica
·
75
PDF
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL
2015
·
Stefano Iacovelli
, Eva Hug
, et al.
·
Blood
·
68
PDF
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells
2022
·
Eugenio Galli
, Federica Sorà
, et al.
·
British Journal of Haematology
·
62
PDF
B‐cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia
2012
·
Francesco Maura
, Carlo Visco
, et al.
·
American Journal of Hematology
·
37
PDF
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
2021
·
Francesco Autore
, Raffaella Pasquale
, et al.
·
Cancers
·
36
PDF
CD200 included in a 4‐marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia
2018
·
Giovanni D'Arena
, Candida Vitale
, et al.
·
Hematological Oncology
·
36
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia
2014
·
A Veronese
, F Pepe
, et al.
·
Leukemia
·
36
PDF
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
2015
·
Luca Laurenti
, Idanna Innocenti
, et al.
·
Leukemia Research
·
32
Role of microRNAs in Chronic Lymphocytic Leukemia
2023
·
Francesco Autore
, Alice Ramassone
, et al.
·
International Journal of Molecular Sciences
·
30
PDF
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia
2020
·
Andrea Corbingi
, Idanna Innocenti
, et al.
·
British Journal of Haematology
·
28
Second haploidentical stem cell transplantation for primary graft failure
2020
·
Sabrina Giammarco
, Anna Maria Raiola
, et al.
·
Bone Marrow Transplantation
·
27
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia
2019
·
Andrea Visentin
, Marina Deodato
, et al.
·
Hematological Oncology
·
25
PDF
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12
2019
·
Francesco Autore
, Paolo Strati
, et al.
·
Cancers
·
25
PDF
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management
2023
·
Eugenio Galli
, Alberto Fresa
, et al.
·
European Journal Of Haematology
·
24
PDF
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
2021
·
Andrea Bacigalupo
, Idanna Innocenti
, et al.
·
Frontiers in Immunology
·
24
PDF
Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response
2021
·
Mirco Di Marco
, Serena Veschi
, et al.
·
Cancers
·
23
PDF
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis
2019
·
Idanna Innocenti
, Francesca Morelli
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
23
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study
2022
·
Idanna Innocenti
, Gianluigi Reda
, et al.
·
Haematologica
·
22
PDF
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b‐precursor acute lymphoblastic leukaemia: Case reports and literature review
2021
·
Federica Sora
, Mario Annunziata
, et al.
·
Pediatric Blood & Cancer
·
20
Venetoclax in CLL patients who progress after B‐cell Receptor inhibitor treatment: a retrospective multi‐centre Italian experience
2019
·
Idanna Innocenti
, Francesca Morelli
, et al.
·
British Journal of Haematology
·
20
PDF
Chlorambucil Plus Rituximab as Front-line Therapy in Elderly/unfit Patients Affected by B-cell Chronic Lymphocytic Leukemia: Results of a Single-centre Experience.
2013
·
Luca Laurenti
, Barbara Vannata
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
20
PDF
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy
2021
·
Fabio Efficace
, Uwe Platzbecker
, et al.
·
Blood Advances
·
18
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia
2018
·
Idanna Innocenti
, Davide Rossi
, et al.
·
Hematological Oncology
·
16
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors
2016
·
Federica Sorà
, Francesca Romana Ponziani
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
16
Show more works
View as search
Works count:
199
Citation count:
1,302
H-index:
20
I10-index:
41
Year
Topic
Type